AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2014
Jan 10, 2014
29745_dirs_2014-01-10_d615768d-1e0a-44ca-acc9-615e8abd1de1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-01-01
Reporting Person: Zulueta Alfonso G (SVP& Pres., Emerging Markets)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 22830 | Direct |
| Common Stock | 3957 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option 2/04 (right to buy) | $73.11 | 2014-02-14 | Common Stock (40000.0) | Direct | |
| Employee stock option 2/05 (right to buy) | $55.65 | 2015-02-10 | Common Stock (21302.0) | Direct | |
| Employee stock option 2/06 (right to buy) | $56.18 | 2016-02-09 | Common Stock (12048.0) | Direct | |
| Restricted Stock Unit | $ | 2014-10-01 | Common Stock (9333.0) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29